No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina / NY / FL

St. Mary’s Medical Center is the First Hospital in Florida to Treat Stroke Patients with Novel TIGERTRIEVERÔ Stroke Device

Editor: What To Know

  • Mary's Medical Center is the first hospital in Florida to remove a blood clot in the brain using Rapid Medical's new TIGERTRIEVER device—the only clot removal tool that is adjustable inside the brain.
  • “Using the TIGERTRIEVER is a breakthrough in our community, and we look forward to providing the level of care needed for patients who come to our comprehensive stroke center.
  • “This new technology gives our team an even better opportunity to capture clots that form in the brain so we can treat someone having a stroke as quickly as possible,” said Dr.

St. Mary’s Medical Center is the first hospital in Florida to remove a blood clot in the brain using Rapid Medical’s new TIGERTRIEVER device—the only clot removal tool that is adjustable inside the brain. TIGERTRIEVER enables neuro interventionalists to better remove blood clots and restore blood flow to the brain following a stroke—a condition that devastates 800,000 Americans annually. Dr. Ali Malek, medical director of the comprehensive stroke center at the hospital, performed the procedure.

“This new technology gives our team an even better opportunity to capture clots that form in the brain so we can treat someone having a stroke as quickly as possible,” said Dr. Ali Malek. “Using the TIGERTRIEVER is a breakthrough in our community, and we look forward to providing the level of care needed for patients who come to our comprehensive stroke center.”

TIGERTRIEVER is the first and only adjustable clot retriever, providing physicians with greater control and adaptability to varying patient anatomy and circumstances. While viewing the device under x-ray guidance, physicians can adjust it to match the vessel size and better capture the clot.

“This is just another example as to why St. Mary’s Medical Center continues to be at the forefront of neurologic care when it comes to treating strokes,” said Cynthia McCauley, chief executive officer of St. Mary’s Medical Center & Palm Beach Children’s Hospital. “We look forward to using this new technology to treat our patients so they can receive the quality care they deserve when they are brought to our hospital.”

St. Mary’s Medical Center is an award-winning Comprehensive Stroke Center providing quality care in stroke prevention, stroke management, and stroke rehabilitation. Our center is equipped with some of the latest diagnostic and therapeutic advances to quickly and accurately diagnose and treat stroke patients. Patients benefit from a range of comprehensive medical, surgical and minimally invasive treatment options, as well as access to clinical trials and research.

For more information on our comprehensive services, go to www.stmarysmc.com or call 561-844-6300.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."

Sedana Medical Completes Patient Recruitment for INSPiRE-ICU 1 Clinical Trial in the US

Peter Sackey further elaborated: "Once the 30-day follow-up of all patients is complete, we will enter into an intense phase of final monitoring, data cleaning and transfer to our statistician team for analysis. In parallel, the long-term outcomes at 3 and 6 months will be collected centrally by the Critical Illness, Brain Dysfunction, and Survivorship team at Vanderbilt Medical Center. With this parallel approach, we expect topline results in the autumn of this year and a swift regulatory submission in Q1, 2025".

Health / Lifestyle

Articles of Interest

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy